| Target Price | $306.00 |
| Price | $284.00 |
| Potential |
7.75%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Laboratory 2026 .
The average Laboratory target price is $306.00.
This is
7.75%
register free of charge
$341.25
20.16%
register free of charge
$262.60
7.54%
register free of charge
|
|
| A rating was issued by 29 analysts: 24 Analysts recommend Laboratory to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratory stock has an average upside potential 2026 of
7.75%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 13.01 | 14.43 |
| 6.97% | 10.89% | |
| EBITDA Margin | 10.72% | 17.27% |
| 2.97% | 61.12% | |
| Net Margin | 5.73% | 9.66% |
| 66.84% | 68.45% |
24 Analysts have issued a sales forecast Laboratory 2025 . The average Laboratory sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Laboratory EBITDA forecast 2025. The average Laboratory EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Laboratory Analysts have issued a net profit forecast 2025. The average Laboratory net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 8.84 | 16.80 |
| 85.32% | 90.05% | |
| P/E | 16.90 | |
| EV/Sales | 1.98 |
25 Analysts have issued a Laboratory forecast for earnings per share. The average Laboratory EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Oct 17 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Oct 17 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Oct 17 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Oct 17 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 25 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Jul 25 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 25 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


